Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2005 4
2006 1
2008 2
2009 4
2010 2
2011 5
2012 4
2013 2
2014 1
2015 3
2016 5
2017 2
2018 4
2019 2
2020 6
2021 4
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Adaptive homeostasis and the p53 isoform network.
Mehta S, Campbell H, Drummond CJ, Li K, Murray K, Slatter T, Bourdon JC, Braithwaite AW. Mehta S, et al. Among authors: braithwaite aw. EMBO Rep. 2021 Dec 6;22(12):e53085. doi: 10.15252/embr.202153085. Epub 2021 Nov 15. EMBO Rep. 2021. PMID: 34779563 Free PMC article. Review.
The p53 story: layers of complexity.
Braithwaite AW, Royds JA, Jackson P. Braithwaite AW, et al. Carcinogenesis. 2005 Jul;26(7):1161-9. doi: 10.1093/carcin/bgi091. Epub 2005 Apr 7. Carcinogenesis. 2005. PMID: 15817608 Review.
YB-1: oncoprotein, prognostic marker and therapeutic target?
Lasham A, Print CG, Woolley AG, Dunn SE, Braithwaite AW. Lasham A, et al. Among authors: braithwaite aw. Biochem J. 2013 Jan 1;449(1):11-23. doi: 10.1042/BJ20121323. Biochem J. 2013. PMID: 23216250 Review.
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.
Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF Jr, Taschner PE, Hainaut P, Soussi T. Leroy B, et al. Among authors: braithwaite a. Cancer Res. 2017 Mar 15;77(6):1250-1260. doi: 10.1158/0008-5472.CAN-16-2179. Cancer Res. 2017. PMID: 28254861 Free PMC article. Review.
Combining TP53 mutation and isoform has the potential to improve clinical practice.
Ray Das S, Delahunt B, Lasham A, Li K, Wright D, Print C, Slatter T, Braithwaite A, Mehta S. Ray Das S, et al. Among authors: braithwaite a. Pathology. 2024 Mar 19:S0031-3025(24)00087-4. doi: 10.1016/j.pathol.2024.02.003. Online ahead of print. Pathology. 2024. PMID: 38594116 Free article. Review.
Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis.
Jesus ANB, Taha A, Wang D, Mehta PM, Mehta S, Reily-Bell A, Lekamlage SP, Saraiva AM, Tahmeedzaman T, Ziad F, Thotathil Z, Gan PYC, Royds J, Braithwaite A, Hung N, Slatter TL. Jesus ANB, et al. Among authors: braithwaite a. Int J Mol Sci. 2023 Jan 9;24(2):1267. doi: 10.3390/ijms24021267. Int J Mol Sci. 2023. PMID: 36674782 Free PMC article.
Cohesin mutations are synthetic lethal with stimulation of WNT signaling.
Chin CV, Antony J, Ketharnathan S, Labudina A, Gimenez G, Parsons KM, He J, George AJ, Pallotta MM, Musio A, Braithwaite A, Guilford P, Hannan RD, Horsfield JA. Chin CV, et al. Among authors: braithwaite a. Elife. 2020 Dec 7;9:e61405. doi: 10.7554/eLife.61405. Elife. 2020. PMID: 33284104 Free PMC article.
59 results